Method of inhibiting interleukin-1 release and alleviating inter

Details Method of inhibiting interleukin-1 release and alleviating inter Method of inhibiting interleukin-1 release and alleviating inter

1990-03-26

1990-12-04

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Sulfur, selenium or tellurium compound

A61U 3110

Patent

active

049754670

ABSTRACT:
Methods useful for inhibiting the release of Interleukin-1 and for alleviating interleukin-1 mediated conditions, such as IL-1 mediated inflammation, comprising administration of an effective amount of an alkylidenedithiobis(substituted)phenol, preferably, 4,4'-(isopropylidenedithio(bis(2,6-di-tert-butyl) phenol, generically known as probucol.

REFERENCES:
patent: 3576883 (1971-04-01), Neuworth
patent: 3704327 (1972-11-01), Neuworth
patent: 3786100 (1974-01-01), Neuworth
patent: 3862332 (1975-01-01), Barnhart et al.
patent: 3897500 (1975-07-01), Neuworth
patent: 4560799 (1985-12-01), Spivack et al.
patent: 4612341 (1986-09-01), Spivack et al.
Tawara, et al. Japan J. Pharmacol. 41, 211-222 (1986).
Yamamoto, et al. Atherosclerosis 62, 209 (1986).
Comal, et al. Drug Dev. Res. 6, 113(1985).
Beaumont, et al. Artery 10, 71(1982).
Yoshino, et al. The Lancet 2, 740-741 (Sep. 27, 1986).
Naruszewicz, et al. J. Lippid Res. 25, 1206 (1984).
Parthasarathy, et al. J. Clin. Invest. 77, 641(1985).
Carew, et al. Proc. Natl. Acad. Sci. U.S.A. 84, 7725, (Nov. 1987).
Ku, et al. Amer. J. Cardiology 62, 77B, (Jul. 1988).
Drash, et al. Amer. J. Cardiology 62, 27B (Jul. 1988).
Neuworth et al., J. Med Chem., 13, 722 (1970).
Ku, Abstract, Second International Conference on Hypercholesterolemia, Los Angeles, CA, Nov. 13-14, 1987.
Steinberg, ibid.
Kita, ibid.
Chisolm, ibid.
Carew et al., Proc. Natl. Acad. Sci. U.S.A., 84, 7725-7729 (1987).
Kita et al., Proc. Natl. Acad. Sci. U.S.A., 84, 5928-5931 (1987).
Marx, Science, 239, 257-258 (1988).
Libby et al., Fed. Proc., 46, No. 3,975, Abstract 3837 (1987).
Pukel et al., Diabetes, 37, 133-136 (1988).
Mandrup-Poulsen et al., J. Immunol., 139, 4077-4082 (1987).
Roe, Geriatrics, pp. 174-182 (1966).
Skinner et al., Arch. Dermatol, 118, 144 (1982)
Innes and Davidson Defensive Publication No. T960003.
Physician's Desk Reference, 41st Edition, 1357-1359 (1987).
Naruszewicz et al., Journal of Lipid Research, 25, 1206 (1984).
Parthasarathy et al., J. Clin. Invest., 77, 641 (1985).
Murphy, Brit. Journal of Rheumatology, 24(1): 6-9 (1985).
Oppenheim et al., Immunology Today, 2, 45-55 (1986).
Billingham, Brit. J. Rheumatology, 24(1):25-28 (1985).
Dayer, Brit. J. Rheumatology, 24(1):15-20 (1985).
Whicher, Brit. J. Rheumatology, 24(1):21-24 (1985).
Pettipher et al., Proc. Natl. Acad. Sci.(U.S.A.), 83, 8749-8753 (Nov. 1986).
Ristow, Proc. Natl. Acad. Sci. (U.S.A.), 84, 1940-1944 (Apr 1987).
Bendtzen et al., Science, 232, 1545-1547 (Jun. 20, 1986).
Camp et al., The Journal of Immunology, 137(11), 3469-3474 (Dec. 1986).
Kent, Geriatrics, 32(1):127-136 (1977).
Feldman et al., Parasite Immunology, 7, 567-573 (1985).
Phan et al., AJP, 124(2), 343-351 (1986).
Kunkel et al., Biochemical and Biophysical Research Comm., 128(2), 892-897 (1985).
Montecchi et al., J. Pharmacol, 15(4), 481 (1984).
Pharmaprojects, 12, 674 (1982).

Affiliated with

Also associated with

Rating

Method of inhibiting interleukin-1 release and alleviating inter does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting interleukin-1 release and alleviating inter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting interleukin-1 release and alleviating inter will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-883816